Expression of Nociceptive Ligands in Canine Osteosarcoma. (8th January 2015)
- Record Type:
- Journal Article
- Title:
- Expression of Nociceptive Ligands in Canine Osteosarcoma. (8th January 2015)
- Main Title:
- Expression of Nociceptive Ligands in Canine Osteosarcoma
- Authors:
- Shor, S.
Fadl‐Alla, B.A.
Pondenis, H.C.
Zhang, X.
Wycislo, K.L.
Lezmi, S.
Fan, T.M. - Abstract:
- <abstract abstract-type="main" id="jvim12511-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jvim12511-sec-0001" sec-type="section"> <title>Background</title> <p>Canine osteosarcoma (OS) is associated with localized pain as a result of tissue injury from tumor infiltration and peritumoral inflammation. Malignant bone pain is caused by stimulation of peripheral pain receptors, termed nociceptors, which reside in the localized tumor microenvironment, including the periosteal and intramedullary bone cavities. Several nociceptive ligands have been determined to participate directly or indirectly in generating bone pain associated with diverse skeletal abnormalities.</p> </sec> <sec id="jvim12511-sec-0002" sec-type="section"> <title>Hypothesis</title> <p>Canine OS cells actively produce nociceptive ligands with the capacity to directly or indirectly activate peripheral pain receptors residing in the bone tumor microenvironment.</p> </sec> <sec id="jvim12511-sec-0003" sec-type="section"> <title>Animals</title> <p>Ten dogs with appendicular OS.</p> </sec> <sec id="jvim12511-sec-0004" sec-type="section"> <title>Methods</title> <p>Expression of nerve growth factor, endothelin‐1, and microsomal prostaglandin E synthase‐1 was characterized in OS cell lines and naturally occurring OS samples. In 10 dogs with OS, circulating concentrations of nociceptive ligands were quantified and correlated with subjective pain scores and tumor volume in patients treated with<abstract abstract-type="main" id="jvim12511-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jvim12511-sec-0001" sec-type="section"> <title>Background</title> <p>Canine osteosarcoma (OS) is associated with localized pain as a result of tissue injury from tumor infiltration and peritumoral inflammation. Malignant bone pain is caused by stimulation of peripheral pain receptors, termed nociceptors, which reside in the localized tumor microenvironment, including the periosteal and intramedullary bone cavities. Several nociceptive ligands have been determined to participate directly or indirectly in generating bone pain associated with diverse skeletal abnormalities.</p> </sec> <sec id="jvim12511-sec-0002" sec-type="section"> <title>Hypothesis</title> <p>Canine OS cells actively produce nociceptive ligands with the capacity to directly or indirectly activate peripheral pain receptors residing in the bone tumor microenvironment.</p> </sec> <sec id="jvim12511-sec-0003" sec-type="section"> <title>Animals</title> <p>Ten dogs with appendicular OS.</p> </sec> <sec id="jvim12511-sec-0004" sec-type="section"> <title>Methods</title> <p>Expression of nerve growth factor, endothelin‐1, and microsomal prostaglandin E synthase‐1 was characterized in OS cell lines and naturally occurring OS samples. In 10 dogs with OS, circulating concentrations of nociceptive ligands were quantified and correlated with subjective pain scores and tumor volume in patients treated with standardized palliative therapies.</p> </sec> <sec id="jvim12511-sec-0005" sec-type="section"> <title>Results</title> <p>Canine OS cells express and secrete nerve growth factor, endothelin‐1, and prostaglandin E2. Naturally occurring OS samples uniformly express nociceptive ligands. In a subset of OS‐bearing dogs, circulating nociceptive ligand concentrations were detectable but failed to correlate with pain status. Localized foci of nerve terminal proliferation were identified in a minority of primary bone tumor samples.</p> </sec> <sec id="jvim12511-sec-0006" sec-type="section"> <title>Conclusions and Clinical Importance</title> <p>Canine OS cells express nociceptive ligands, potentially permitting active participation of OS cells in the generation of malignant bone pain. Specific inhibitors of nociceptive ligand signaling pathways might improve pain control in dogs with OS.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of veterinary internal medicine. Volume 29:Number 1(2015:Jan./Feb.)
- Journal:
- Journal of veterinary internal medicine
- Issue:
- Volume 29:Number 1(2015:Jan./Feb.)
- Issue Display:
- Volume 29, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 29
- Issue:
- 1
- Issue Sort Value:
- 2015-0029-0001-0000
- Page Start:
- 268
- Page End:
- 275
- Publication Date:
- 2015-01-08
- Subjects:
- Veterinary medicine -- Periodicals
636.0896 - Journal URLs:
- http://www.jvetintmed.org ↗
http://www3.interscience.wiley.com/journal/118902531/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jvim.12511 ↗
- Languages:
- English
- ISSNs:
- 0891-6640
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5072.365000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3518.xml